Physician profile
Aisha Sesay
NPI 1841876000
$2,827.30
in general payments reported to CMS, 2019-2025
21 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.12 · 2023: $47.94 · 2024: $934 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,699 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,699.29 |
| Education | $112.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $533.57 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $292.26 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Medtronic, INC. | $266.97 | 2025 | Symplicity G3, Minimed 780g |
| Viiv Healthcare Company | $237.36 | 2024-2025 | Apretude |
| Abbvie INC. | $236.06 | 2024-2025 | |
| Astellas Pharma US INC | $218.47 | 2024-2025 | Veozah |
| Lilly USA, LLC | $171.02 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $147.38 | 2024-2025 | |
| Gilead Sciences, INC. | $144.89 | 2025 | |
| Exact Sciences Corporation | $97.25 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $96.88 | 2025 | Repatha, Evenity, Otezla |
| Dexcom, INC. | $87.32 | 2024-2025 | Dexcom G6 Transmitter |
| Alk-Abello, INC | $76.42 | 2025 | Neffy |
| Aerin Medical INC. | $41.67 | 2025 | |
| Merck Sharp & Dohme LLC | $37.28 | 2025 | Capvaxive, Gardasil 9 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $28.41 | 2024-2025 | Flucelvax, Fluad |
| 3b Medical, INC. | $23.64 | 2025 | Luna |
| Abbott Laboratories | $23.42 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $22.85 | 2025 | Shingrix, Arexvy |
| Tandem Diabetes Care, INC. | $22.42 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Inspire Medical Systems, INC. | $21.76 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Sesay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.